TY - JOUR
T1 - Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation:
T2 - A Narrative Review of the Extent of and Factors in Guideline Non-adherence
AU - Gebreyohannes, Eyob Alemayehu
AU - Salter, Sandra
AU - Chalmers, Leanne
AU - Bereznicki, Luke
AU - Lee, Kenneth
N1 - Funding Information:
Mr. Eyob Alemayehu Gebreyohannes is a Ph.D. student and a recipient of the University of Western Australia International Fee Scholarship and University Postgraduate Award. Mr. Gebreyohannes would like to acknowledge the University of Western Australia for supporting his studies.
Publisher Copyright:
© 2020, Springer Nature Switzerland AG.
PY - 2021/7/28
Y1 - 2021/7/28
N2 - Atrial fibrillation is the most common arrhythmia. It increases the risk of thromboembolism by up to fivefold. Guidelines provide evidence-based recommendations to effectively mitigate thromboembolic events using oral anticoagulants while minimizing the risk of bleeding. This review focuses on non-adherence to contemporary guidelines and the factors associated with guideline non-adherence. The extent of guideline non-adherence differs according to geographic region, healthcare setting, and risk stratification tools used. Guideline adherence has gradually improved over recent years, but a significant proportion of patients are still not receiving guideline-recommended therapy. Physician-related and patient-related factors (such as patient refusals, bleeding risk, older age, and recurrent falls) also contribute to guideline non-adherence, especially to undertreatment. Quality improvement initiatives that focus on undertreatment, especially in the primary healthcare setting, may help to improve guideline adherence.
AB - Atrial fibrillation is the most common arrhythmia. It increases the risk of thromboembolism by up to fivefold. Guidelines provide evidence-based recommendations to effectively mitigate thromboembolic events using oral anticoagulants while minimizing the risk of bleeding. This review focuses on non-adherence to contemporary guidelines and the factors associated with guideline non-adherence. The extent of guideline non-adherence differs according to geographic region, healthcare setting, and risk stratification tools used. Guideline adherence has gradually improved over recent years, but a significant proportion of patients are still not receiving guideline-recommended therapy. Physician-related and patient-related factors (such as patient refusals, bleeding risk, older age, and recurrent falls) also contribute to guideline non-adherence, especially to undertreatment. Quality improvement initiatives that focus on undertreatment, especially in the primary healthcare setting, may help to improve guideline adherence.
KW - ADHERENCE
KW - ANTITHROMBOTIC THERAPY GUIDELINES
KW - ELDERLY-PATIENTS
KW - INSIGHTS
KW - MANAGEMENT
KW - ORAL ANTICOAGULANTS
KW - PRESCRIPTION
KW - RISK
KW - STROKE PREVENTION
KW - UNDERUSE
UR - https://doi.org/10.1007/s40256-020-00457-3
UR - http://www.scopus.com/inward/record.url?scp=85098198698&partnerID=8YFLogxK
U2 - 10.1007/s40256-020-00457-3
DO - 10.1007/s40256-020-00457-3
M3 - Review article
VL - 21
SP - 419
EP - 433
JO - American Journal of Cardiovascular Drugs
JF - American Journal of Cardiovascular Drugs
SN - 1175-3277
IS - 4
ER -